NDC 51662-1375-01 - FAMOTIDINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1375
- Requested NDC
- 51662-1375-01
- Package NDCs from labels
- 51662-1375-1, 51662-1375-2, 51662-1375-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2022-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FAMOTIDINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1375-1 | FAMOTIDINE | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 3 | |
| 51662-1375-2 | FAMOTIDINE | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 3 | |
| 51662-1375-2 | FAMOTIDINE | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1375 | FAMOTIDINE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 3 package rows | 20221002_9948991d-9405-c7c8-e053-2995a90a60ca.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | A-S Medication Solutions | 74ff64f2-d882-411f-bac8-29dfa4cb4f10 | 2023-08-09 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Maximum Strength Acid Controller | FAMOTIDINE | BETTER LIVING BRANDS LLC. | f2c031b4-de86-3a8e-e053-2a95a90a21e0 | 2023-07-30 | Warnings | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Biocon Pharma Inc. | ea7287a4-75e0-39d2-5b2e-b72b7cb386b9 | 2023-05-21 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Medical Purchasing Solutions, LLC | bbeffa0a-2bc7-fea4-e053-2a95a90ac511 | 2023-05-08 | Warnings, Adverse reactions | 1743833 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Medical Purchasing Solutions, LLC | b6214fc9-a274-ef45-e053-2a95a90ae43a | 2023-05-04 | Adverse reactions | 1743833 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | BluePoint Laboratories | befd8d44-c6f7-eca2-e053-2995a90a714b | 2023-03-23 | Warnings | 5QZO15J2Z8 |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| IBUPROFEN AND FAMOTIDINE | IBUPROFEN AND FAMOTIDINE | Ascent Pharmaceuticals, Inc. | 03733e49-7db4-4d98-b363-d0d23686ec72 | 2023-03-15 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | fe21daca-ac48-4b46-9cb3-9a69af0c6a84 | 2023-03-01 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Zydus Pharmaceuticals USA Inc. | a8010e10-68fd-455f-968f-d62a1c3e0ffd | 2022-12-02 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Fresenius Kabi USA, LLC | aeb27cea-1ff7-4a6e-93f1-d4c4dac5faa7 | 2022-11-08 | Warnings, Adverse reactions | ANDA075813 63323-739 1743833 7411dc23-e297-42cb-b491-b90d70c841a3 aeb27cea-1ff7-4a6e-93f1-d4c4dac5faa7 5QZO15J2Z8 |
| Spectric | ETHYLICUM, KALI BROMATUM, ASPARTIC ACID, L-DOPA, SEROTONIN (HYDROCHLORIDE), CEREBRUM SUIS, PLACENTA TOTALIS SUIS, AGARICUS MUSCARIUS, BUFO RANA, HELLEBORUS NIGER, HYOSCYAMUS NIGER, OLIBANUM (BOSWELLIA SERRATA), STRAMONIUM, THUJA OCCIDENTALIS, HELIUM, NEON, CARCINOSIN, HYDROGEN | Deseret Biologicals, Inc | 3e534017-4a9f-42a2-bdfd-1e8c73c0515a | 2022-11-08 | Warnings | 30KYC7MIAI |
| Famotidine | FAMOTIDINE | Fresenius Kabi USA, LLC | 5995d726-f3f8-4c2d-af19-1b12e3f769c6 | 2022-10-20 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| famotidine | FAMOTIDINE | Camber Consumer Care Inc | ebe3ca30-df25-4c56-8935-414a3431b5b9 | 2022-10-11 | Warnings | 5QZO15J2Z8 |
| topcare acid reducer | FAMOTIDINE | Topco Associates LLC | 7824fdab-cdd5-457d-9b14-b82b19ea9529 | 2022-10-03 | Warnings | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | HF Acquisition Co LLC, DBA HealthFirst | 9948991d-9405-c7c8-e053-2995a90a60ca | 2022-10-01 | Adverse reactions | ANDA075813 51662-1375-2 51662-1375-1 51662-1375 51662137501 1743833 e9fd11b6-5cbd-ba83-e053-2a95a90a42af 9948991d-9405-c7c8-e053-2995a90a60ca 5QZO15J2Z8 |
| famotidine | FAMOTIDINE | Navinta LLC | 0f34a3be-7554-4040-b808-5ba8bf064abc | 2022-09-17 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| injoy heartburn relief | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | L. Perrigo Company | aca1b9e5-a35e-4eef-b55a-4189cd1b2a02 | 2022-09-07 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | f32d0929-de22-4bec-9e24-bb549cf2679f | 2022-09-01 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Zantac 360 2 per blister 6 blisters | FAMOTIDINE | JC World Bell Wholesale Co., Inc. | fd61a2d6-5c8a-4e7a-8b19-37406b90f778 | 2022-08-15 | Warnings | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.